Outcomes of Cytoreductive Surgery for Well-Differentiated Metastatic Neuroendocrine Tumors in the Setting of Extra-Hepatic Metastases Abstract #1352

Introduction: Cytoreduction with extra-hepatic disease for neuroendocrine tumors (NET) remains controversial
Aim(s): To define the outcomes of cytoreduction for metastatic NETs in the setting of extra-hepatic metastates.
Materials and methods: Patients undergoing cytoreductive surgery for G1 or G2 NETs with extra-hepatic metastases were identified from an institutional database (2003-2014). Primary outcomes were post-operative hormonal response, progression-free and overall survival (PFS, OS).
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: Hallet Julie

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1349 Access to Care and Outcomes for Neuroendocrine Tumors: Does Socio-Economic Status Matter? A Population-Based Analysis.
Introduction: Neuroendocrine Tumors (NET) lack standardized care. Differences in socioeconomic status (SES) worsen the impact of non-standardized care.
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Hallet Julie
#14 Radioguided surgery in NET: First impression with Ga-68 labeled somatostatin analogues
Introduction: Neuroendocrine tumors (NET) constitute a heterogenous group of neoplasms. The development of Gallium-68-labeled somatostatin analogues, such as DOTA-NOC or DOTA-TOC, PET/CT have dramatically improved the diagnosis of neuroendocrine tumors. Surgery remains the treatment of choice for localized disease as well as metastatic disease. The aims of surgery are: improvement of symptoms, reduction of tumor mass / burden and to give better quality of life to patients. Recurrent laparotomies often lead to multiple adhesions and altered anatomy. So it is increasingly difficult for imaging physicians and surgeons to separate non-malignant from malignant tissue.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr. Daniel Kaemmerer
#1746 Clinical Outcomes in Small Neuroendocrine Tumours Treated with Intestinal Surgery in Tertiary Centre
Introduction: Patients with Small Bowel Neuroendocrine Tumours (SBNET) may require small bowel surgery either as an emergency or electively.Robust data from Tertiary Referral Centres (TRC) are lacking.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Georgios Demetriou
#1716 Trans-Anal Minimally Invasive Surgery (TAMIS) for Completion Local Excision of Well-Differentiated Rectal Neuroendocrine Tumours.
Introduction: Rectal NETs (R-NETs) <2cm are often amenable to endoscopic resection, but initial resections are often incomplete, and extended monitoring or radical surgery may then be required. Trans-anal minimally invasive surgery (TAMIS) allows resection of rectal tumours while reducing surgical morbidity. Data on its use in R-NETs is scant.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: Dr David Chan
Authors: Chan D, Law C, Hallet J, Singh S, ...
Keywords: TAMIS
#485 Laparoscopic Surgery of Pancreatic Neuroendocrine Tumors: Results From a Tertiary Care Institution
Introduction: There are only a few series describing feasibility and short-term-outcome of laparoscopic surgery of pancreatic neuroendocrine tumors (pNET).
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: MD Sven-Petter Haugvik